ctDNA Blood Test for Cancer Monitoring Launches in Europe
German laboratory brings tumor-informed MRD testing to European market through licensing agreement with Quest Diagnostics subsidiary.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Cancer |
German laboratory brings tumor-informed MRD testing to European market through licensing agreement with Quest Diagnostics subsidiary.
Read MorePosted by CLP Edit Staff | Oct 10, 2025 | Molecular Diagnostic Analyzers |
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Read MorePosted by CLP Edit Staff | Oct 10, 2025 | Cancer |
OncoGenDx analyzes 335 DNA genes and 72 RNA genes using next-generation sequencing technology to support treatment decisions.
Read MorePosted by CLP Edit Staff | Oct 9, 2025 | Diagnostic Technologies |
Researchers are developing a large-scale olfactory dataset to train artificial intelligence, potentially unlocking smell as a powerful tool for early disease detection.
Read MorePosted by CLP Edit Staff | Oct 1, 2025 | Lung Cancer |
A new blood-based test that combines four protein markers with artificial intelligence has demonstrated potential for early lung cancer detection in a multicenter retrospective study.
Read More